DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | Heo, Won Do | - |
dc.contributor.advisor | 허원도 | - |
dc.contributor.author | Yu, Daseuli | - |
dc.date.accessioned | 2021-05-12T19:40:27Z | - |
dc.date.available | 2021-05-12T19:40:27Z | - |
dc.date.issued | 2020 | - |
dc.identifier.uri | http://library.kaist.ac.kr/search/detail/view.do?bibCtrlNo=909397&flag=dissertation | en_US |
dc.identifier.uri | http://hdl.handle.net/10203/284170 | - |
dc.description | 학위논문(박사) - 한국과학기술원 : 생명과학과, 2020.2,[v, 99 p. :] | - |
dc.description.abstract | Intracellular antibodies, such as nanobodies and single-chain variable fragments (scFv), have become powerful tools for imaging, modulating, and neutralizing endogenous target proteins. Although a variety of antibody engineering techniques have been developed, an optogenetic tool for activating intracellular antibody to precisely control its target protein has not been reported. In chapter 1, I describe an optogenetically activatable intracellular antibody (Optobody) consisting of split antibody fragments and blue light-mediated heterodimerization domains. Blue light stimulation activates the optobody, inducing it to capture its target protein and subsequently inhibit the target. In chapter 2, I expanded this optobody platform by generating various optobodies from previously developed intracellular antibodies. In chapter 3, I demonstrated that photoactivation of a gelsolin (GSN) optobody and $\beta$2 adrenergic receptor ($\beta$2AR) optobody shut down endogenous GSN activity and $\beta$2AR signaling, respectively. Applying the novel optogenetic platform to the broad pool of available intracellular antibodies will facilitate optogenetic manipulation of various endogenous proteins and may provide a basis for designing potential inducible drugs. | - |
dc.language | eng | - |
dc.publisher | 한국과학기술원 | - |
dc.subject | Optogenetics▼aAntibody fragments▼aNanobody▼ascFv▼aOptobody▼aEndogenous protein inhibition▼aAntibody-based drug | - |
dc.subject | 광유전학▼a항체 조각▼a나노바디▼ascFv▼a광활성 항체▼a옵토바디▼a내생단백질 기능 저해▼a항체 의약품 | - |
dc.title | Optogenetic activation of intracellular antibodies for direct modulation of endogenous proteins | - |
dc.title.alternative | 항체광유전학 기술 개발을 통한 세포 내 단백질 기능 연구 | - |
dc.type | Thesis(Ph.D) | - |
dc.identifier.CNRN | 325007 | - |
dc.description.department | 한국과학기술원 :생명과학과, | - |
dc.contributor.alternativeauthor | 유다슬이 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.